Illumina introduces simplest, fastest benchtop sequencers, MiSeq i100 Series: San Diego Friday, October 11, 2024, 18:00 Hrs [IST] Illumina, Inc., a global leader in DNA sequencing ...

Arbele inks collaboration with BioAI Health to develop prototype of immunohistochemistry based quantification algorithm: Seattle Friday, October 11, 2024, 16:00 Hrs [IST] Arbele, ...

Denovo Biopharma receives US FDA fast track designation for its liafensine for treating patients with treatment-resistant depression: San Diego Friday, October 11, 2024, 17:00 Hrs ...

Abbott Park, Illinois Friday, October 11, 2024, 15:00 Hrs [IST] ...

GSK to resolve 93% of US state court Zantac product liability cases for up to $2.2 billion: London, UK Friday, October 11, 2024, 14:00 Hrs [IST] GSK plc announced that it has reac ...

Bad Vilbel, Germany Friday, October 11, 2024, 13:00 Hrs [IST] ...

Alexion to present data from its leading generalised myasthenia gravis portfolio at 2024 AANEM annual meeting: Cambridge, UK Friday, October 11, 2024, 13:30 Hrs [IST] Alexion, Ast ...

Pfizer announces positive results from phase 3 TALAPRO-2 trial of Talzenna in combination with Xtandi in patients with mCRPC: New York Friday, October 11, 2024, 09:00 Hrs [IST] Pf ...

Our Bureau, Mumbai Friday, October 11, 2024, 11:30 Hrs [IST] ...

RxDx Assay to identify patients with gastric or GEJ cancer gets CE Mark approval: Basel Friday, October 11, 2024, ...

US FDA accepts Bayer’s NDA for elinzanetant to treat moderate-to-severe VMS associated with menopause: Berlin Friday, October 11, 2024, 11:00 Hrs [IST] Bayer announced that the ...

AI-driven screening at NURA pioneers early detection of breast cancer during breast cancer awareness month 2024: Our Bureau, Mumbai Friday, October 11, 2024, 12:15 Hrs [IST] Octob ...